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T cell immunoengineering with advanced
biomaterials
Derfogail Delcassian,*ab Susanne Sattlerc and Iain E. Dunlop*d
Recent advances in biomaterials design oﬀer the potential to actively control immune cell activation and
behaviour. Many human diseases, such as infections, cancer, and autoimmune disorders, are partly
mediated by inappropriate or insuﬃcient activation of the immune system. T cells play a central role in
the host immune response to these diseases, and so constitute a promising cell type for manipulation.
In vivo, T cells are stimulated by antigen presenting cells (APC), therefore to design immunoengineering
biomaterials that control T cell behaviour, artificial interfaces that mimic the natural APC-T cell
interaction are required. This review draws together research in the design and fabrication of such
biomaterial interfaces, and highlights eﬀorts to elucidate key parameters in T cell activation, such as
substrate mechanical properties and spatial organization of receptors, illustrating how they can be
manipulated by bioengineering approaches to alter T cell function.
Insight, innovation, integration
Controlled immune cell activation is emerging as a powerful strategy in a range of clinical therapies. This review describes current progress in designing
biomimetic structures that direct T cell behaviour. This new field integrates fundamental research in immune cell biophysics, including receptor
nanopatterning and mechanotransduction, together with applied biomaterial design. We comprehensively summarize the current state of the field and
advocate a future direction for innovative immunomodulatory biomaterials through the integration of spatial, temporal and mechanical cellular cues in 2- and
3-dimensional therapeutics.
Introduction
Traditionally, biomaterials have been deliberately designed to
minimize interactions with the host immune system when
implanted. The desire for ‘‘immune inert’’ materials that avoid
in vivo immune interactions, such as inflammation,1 fibrosis
and encapsulation2,3 and ultimately rejection4–6 has been a
major focus of tissue engineering over the last few decades. In
contrast, there is a recent growth of interest in materials that
achieve the opposite effect; directly influencing immune cell
behaviour to control immune cell growth and differentiation,
regulate inflammation or induce tolerance; effectively developing
engineered materials that can direct immune cell behaviour.7–9
The development of such immunoengineering biomaterials
is still a nascent field; however its rise has coincided with the
rapid development of biotechnology techniques that direct the
immune response. Prominent examples of this technology are
genetically engineered Chimeric Antigen Receptor (CAR) T cells
which eﬃciently target leukemic cancers,10–12 and nanoparticle
drug delivery strategies for targeted immune cell vaccination.13–16
These fields promise the design of advanced T cell therapeutics
that can deliver appropriate stimuli to T cells to tackle a range of
disease targets. Several key parameters controlling T cell activation
and behaviour have been identified, and the design of biomaterials
capable of manipulating these features presents a new approach to
directing T cell behaviour.
In vivo, T cells are exposed to distinct stimuli that influence
their behaviour, shown schematically in Fig. 1A. These stimuli,
or ‘‘cellular cues,’’ can be loosely classified as physical (including the
topographical, geometrical and mechanical nature of the cell–
substrate interface) or biochemical (including engagement of cell
surface receptors and response to soluble factors). To avoid aberrant
immune responses under physiological conditions, in vivo T cell
activation is a tightly controlled process, depending on Antigen
Presenting Cells (APC) providing antigen-specific signals (signal 1)
and co-stimulation (signal 2), alongside the stimulation provided by
the surrounding cytokine milieu (signal 3).17
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Of particular importance to appropriate T cell activation is the
formation of a closely-adhered immunological synapse between
the T cell and APC (Fig. 2B and C) where a large number of ligand–
receptor pairs combine to form a complex structure18,19 that
determines the T cell’s activation and downstream differentiation.
Peptide-bearing Major Histocompatibility Complex (pMHC)
presented by APCs engages with the T cell receptor (TCR) on
T cells to create an initial activation signal. Secondly, a co-stimulatory
ligand–receptor pair, such as surface receptors CD28/CD80, is
engaged to support full activation, as shown in Fig. 1B.
Additional signals, such as those provided by the cytokine
milieu, provide the third signal to allow eﬀector T cells to expand
and exhibit their full function.5,20 This tightly regulated stimulation
and co-stimulation is crucial to maintaining healthy T cell function.
Without eﬃcient co-stimulation, antigen presentation can lead
to T cell anergy, while inappropriate response to one or more of
these signals may cause hyperinflammatory conditions, such as
allergy or autoimmunity.21 Signal 1, where the T Cell Receptor
(TCR)/CD3 complex recognises the pMHC on APCs, is central in
initiating T cell activation. Alternatively, in the absence of
pMHC, anti-CD3 can be used to engage the TCR/CD3 complex
and can provide a non-antigen specific stimulus as signal 1.
Most research into modulation of T cell function by biomaterials
has focused on TCR- or CD3-mediated activation.22–24 The precise
physical nature of pMHCpresentation to the TCR is critical for T cell
activation; factors including agonist valency,25–29 the mechanical
properties of the activating surface30,31 and the spatial organisation
of stimulatory ligands32–37 have been identified as key features
modulating T cell function in response to stimulation.
Recently, a number of research groups have attempted to
explore the ability of these variables to control cellular behaviour,
using advanced biomaterials that replicate specific properties of
the APC surface. Studies have explored a wide range of para-
meters, including spatial structuring by both photolithography
and self-assembly methods, and the use of bio-functionalized
hydrogels and rubbers to vary mechanical properties. Here,
we consider materials that are designed to directly explore
these parameters, and their eﬀects on T cells. We will examine
both 2D and 3D biomaterials, and consider them in order
of increasing complexity. Specifically, we will focus first on
materials that present a static surface to the cell, secondly on
those that are responsive (interfaces the cell can manipulate
or rearrange) and finally we discuss the move towards sub-
strates that can dynamically manipulate cellular behaviour in
response to external stimuli, summarized in Table 1. This
focused review draws together these experiments to provide
a new perspective on the design of immunomodulatory
materials, and summarizes work completed so far in the move
towards ‘‘immune directing’’ biomaterials for the control of
T cell function.
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Biomaterials for T cell activation
2-Dimensional interfaces
The region of contact between an immune cell and an antigen
presenting cell (APC) is termed the immunological synapse.
Usually this interface includes known activatory, inhibitory or
adhesion molecules arranged in an organised manner.19,53–55
In vitro, this interaction can be replicated by creating advanced
biomaterials that replicate specific properties of the APC
surface, functionalized with ligands that bind specifically to
Fig. 2 Schematic of T cell stimulation and 2D biomaterials interfaces controlling TCR movement. (A) Schematic of a single TCR/CD3 complex (B) a
schematic of hypothetical micro-cluster formation; individual TCR/CD3 complexes associate to form nano-domains, which pre-exist on the T cell
surface. On engagement with APC, TCR/CD3 micro-clusters form (C) a schematic of activation, where TCR/CD3 micro-clusters move from the
periphery to a central Super Molecular Activation Cluster (c-SMAC), and become surrounded by rings of costimulatory and adhesion molecules. (D) Using
chromium barriers on fluid lipid bilayers restricts micro-cluster formation and so synapse structure46 (E) nanopatterns fabricated using block copolymer
micellar lithography present anchoring surfaces for TCR/CD3 ligands with precise inter-ligand spacing (scale bar 100 nm) such surfaces show dramatic
diﬀerences in their ability to activate T cells. This may be due to bound nanoclusters being spaced too far apart on surfaces with large inter-ligand density,
with nanoclusters unable to concatenate if pinned to static nanoparticles, preventing TCR/CD3 micro-cluster formation and so signalling, shown
schematically (altered from ref. 39). Copyright: (D) adapted from ref. 46 Mossman et al., Science, 2005, 310(5751), 1191–1193. Reprinted with permission
from AAAS; (E) adapted with permission from ref. 39 Delcassian et al. Nano Lett., 2013, 13(11), 5608–5614, Copyright 2013 American Chemical Society.
Fig. 1 Schematic of T cell interactions. (A) T cells experience a range of stimuli in vivo that can be broadly classified into biochemical and physical cues.
(B) The TCR/CD3 complex is central to T cell activation, requiring engagement of peptide-bearing MHC (pMHC) with the TCR/CD3 complex, CD4 on the
T cell surface with pMHC on the APC cell surface, and stimulation through CD28 binding to CD80/CD86.
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known receptors on the immune cell surface. These materials
can be used to form an artificial model of the immune synapse
that can engage with cells. Here, we review artificial interfaces
that explore the spatial and physical presentation of T cell
ligands in 2D.
Spatially-controlled presentation of biomolecular cues. The
spatial organisation of cell surface proteins at immune synapse
interfaces, and the dynamic organisation of these proteins, is a
central part of immune cell signalling.18,54 T cells have many
proteins and lipids organised into nanoscale molecular clusters
(nanodomains) on their cell surface, these contain a collection
of distinct receptors and signalling molecules including the
TCR/CD3 complex, and signalling molecules Lat, Zap-70 and
SLP-76.56–58 Upon activation, microclusters, each containing
several nanodomains, move across the cell surface to form
Super Molecular Activatory Clusters (SMACs) containing several
distinct protein domains (Fig. 2C).
The movement of protein and lipid molecules across the
cell surface into central c-, peripheral p- and distal d-rings
surrounding a central feature point is a key step in T cell
activation mediated by the intracellular cytoskeleton.59–65 Early
artificial immune synapses used fluid lipid bilayers to explore
the formation and movement of these dynamic protein
domains.33,66 Fluid lipid bilayer substrates are coated with
phospholipid molecules which mimic the natural bilayer found
in the cell membrane, and can be loaded with proteins that can
engage with cell surface receptors. On activation, the cell may
rearrange proteins expressed on the cell surface into activatory
clusters, causing the proteins embedded in the fluid bilayer,
and those engaged with receptors on the cell surface, to be
redistributed. This allows the cell to re-arrange the proteins
embedded in the fluid bilayer interface. To explore activation
through the TCR, pMHC molecules specific to the cognate TCR
can be introduced into the lipid bilayer. Alternatively, anti-CD3,
which does not require a specific match to bind to the TCR/CD3
complex, can be used. By using these TCR agonists in conjunction
with advanced microscopy techniques, the formation and
movement of individual TCRs and TCR protein micro-clusters
during cellular activation have been explored.
These studies showed that during T cell activation, TCR/CD3
micro-clusters form in the p-SMAC and are transported to the
c-SMAC,60,67 as illustrated in Fig. 2C. The movement of TCR
clusters across the cell surface to the c-SMAC on activation is
now known to propagate and aid sustained signalling in T cells,
and is thought to be mediated by F-actin61,68 and myosin II.69
By adding nanoscale chromium barriers to the fluid bilayer,
more advanced substrates prevented the movement of TCRs in
certain directions (Fig. 2D). Through directing and constraining the
TCR micro-cluster mobility, signalling in the cell can be controlled;
signalling is maximised if TCRmicro-clusters are constrained to the
p-SMAC using these devices.46,70 In an alternative approach,
synthetic polymer chains which present anti-CD3 and anti-CD28
at specific sites on a semi-flexible poly(isocyano peptide) polymer
chain have been used to activate T cells. The polymers present
multiple copies of the antibodies on a single chain, and so enable
multivalent receptor interactions. These are thought to lead to
surface receptor rearrangements and activation of the T cell.71
Intriguingly, T cells display distinct patterns of micro-cluster
proteins both before and during activation.72,73 These patterns
typically demonstrate a TCR/CD3 enriched protein domain in
the c-SMAC surrounded by a ring dominated by adhesion receptor
LFA-1. The TCR/CD3 domains may display a bulls-eye or multi-
focular pattern within the LFA-1 domain, depending on cell
phenotype, maturity and activation status.32,36,74–76
To explore the importance of these micro-features, and the
ways in which changes in protein distribution can control cellular
activation, planar substrates with a range of protein micropatterns
have been fabricated by microcontact printing. In one example,
anti-CD3 was micropatterned in a focal or annular patch, and the
activation response of T cells on these substrates measured by
cytokine secretion. Much higher secretion of the cytokine IFN-g
occurred on patterns with focal anti-CD3 protein organisation
compared to annular rings, even when the amount of antigen
presented was the same. The inclusion of co-stimulatory agents
such as anti-CD28 augmented activation, however positioning
anti-CD3 and anti-CD28 in separate distinct focal points (rather
than a singular focal point patterned with both stimuli) resulted
in much higher IL-2 production.47 Separately, recent work has
shown that regulatory T cells (Treg) display a reduced sensitivity
to micropatterns in comparison to eﬀector T cells,76 whilst
functionally distinct subsets of CD4+ eﬀector T cells (Th1 and
Th2) form distinct patterns in their immunological synapse
with APCs.74,75
Clearly, T cell activation is partly driven by spatial TCR
micro-cluster distribution and movement; thus a logical next
step explored whether controlling the dynamics of formation of
these TCR micro-clusters could control T cell behaviour. Many
studies indicate that smaller TCR nano-domains exist prior to
ligand engagement, and that these nano-domains may play
a significant role in the process of micro-cluster formation.
Super-resolution microscopy has been used to explore the size
Table 1 Complexity in T cell biomaterials design and classifications. An
overview of the parameters currently explored in T cell advanced biomaterials
design, and parameter combinations that have not yet been studied. Interfaces
are classified as static (fixed stimulatory substrates), responsive (cells can
remodel substrates) or dynamic (substrates can be altered based on external
stimuli to instruct cells). Cellular cues can be either chemical or physical,
occurring in 2D or 3D, and on the micro- or nanoscale. Example references
are included to illustrate some of the research performed in these areas
Class Description Micro-scale Nano-scale
Static Chemical 2D 32 and 38 39–42
3D 43 44
Physical 2D 31 and 45
3D
Responsive Chemical 2D 36 46 and 47
3D 48 and 49
Physical 2D
3D
Dynamic Chemical 2D
3D 50 51 and 52
Physical 2D
3D
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of these pre-clustered TCR nano-domains on the surface of
T cells; individual TCR complexes (10–20 nm in size) have been
recorded24 and TCR nano-domains of 35–70 nm in size have
been reported on non-activated T cells.56,60,77–80 On activation,
these nano-domains are hypothesized to associate, transitioning
from individual nanoscale units to larger structures, as illustrated
in Fig. 2B.81 Indeed, such pre-clustering of TCR complexes may
facilitate T cell activation by easing micro-cluster formation,
and similar pre-clustering is also seen in other immune cell
types.79,80,82–86
To explore the relationship between individual TCR receptors,
potential pre-clustered nano-domains and micro-clusters, several
research groups developed nano-interfaces fabricated using
the self-assembly-based block copolymer micellar lithography
technique. This allowed the precise positioning of gold nano-
particles (Fig. 2E) with controllable inter-particle distance that
were subsequently functionalised with TCR agonists such as
anti-CD3 or pMHC. Using this fabrication technique, we and
others showed that early stage activation in human and mouse
CD4+ T cells was a function of inter-particle spacing.39–42 As
inter-particle spacing was increased from 25 to 100 nm, activation
decreased, and above an inter-ligand threshold of approximately
100–150 nm, T cells were unable to activate despite the presence
of stimulatory receptors. These observations are in line with the
biological observation that triggering full T cell activation
requires activation signals to exceed a certain threshold, in which
TCR ligand density plays a key role.25,26,87,88 There are several
potential explanations for this observation; primarily we consider
a minimum density of receptor engagement, receptor cluster
concatenation and/or minimum force requirements to be likely
candidate models.
Fig. 2E illustrates one hypothesis; that pre-clustered TCR
nano-domains are required to concatenate before micro-cluster
formation, transport and sustained signalling can occur. If
receptor nano-domains are bound too far apart, they are unable
to concatenate and induce signalling. This is supported by the
observed spacing activation threshold ofB70 nm, corresponding
well to the nano-domain length scale of 35–70 nm as measured
by Lillemeier et al.81 Further supporting the role of clustering in
cellular activation, interfaces fabricated using a single walled
carbon nanotube composite have been used to activate T cells.
Nanotubes coated with anti-CD3 protein and embedded in a
polymer matrix enhanced T cell activation compared to cells
stimulated using soluble agonist at the same concentration.89–91
The induction of efficient T cell proliferation for immunological
assays has long relied on coating anti-CD3 and anti-CD28 onto
standard tissue culture plates or onto beads to induce TCR cross-
linking, as soluble antibodies do not induce efficient activation,
suggesting that pre-clustering antibodies enhances stimulation.
A separate hypothesis considers engagement of a minimum
number of receptors within a particular sub-cellular location,
which may be required to allow signalling and stimulation to
overcome the intrinsic activation threshold in immune cells
necessary to protect from aberrant activation.92,93 Although receptor–
receptor proximity, and even the proximity of several different
receptor types to one another, clearly plays an important role in
controlling cellular activation, such spatial effects are intrinsically
coupled to receptor and cytoskeletal mechanics. In positioning
receptor ligands precisely, nano- and micro-patterned interfaces
also alter the position and number of traction anchoring points
for the cell. This means that the observed effects of nanoscale
ligand patterning could arise directly from the mechanical
activation of the TCR, hinting that T cell stimulation requires
a certain force to be applied through each TCR to allow
conformational changes, and activation, downstream of TCR
engagement.20,31,37,63,94,95 Interestingly, an intact actin cytoskeleton
appears to be crucial for T cell–APC interactions; without actin,
several receptors are unable to form the described micro-clusters,
and protein rearrangement crucial for signalling cannot occur.59,62
Both F-actin and myosin IIA are thought to play a key role in the
movement of cell surface proteins during TCR activation, and
the dynamic polarisation/depolarisation of intracellular actin is
key to the directional formation of the SMAC.59,61,68,69 Despite
these observations, the nature of the dynamic relationship
between applied mechanical force, cytoskeletal rearrangement,
TCR stimulation and the level of downstream cell activation is
not yet fully elucidated.96,97 In order to fully understand such
effects, more complex interfaces that orthogonally vary ligand
patterning and substrate mechanical properties are needed.
Typically, silicon or glass materials have been used as underlying
substrates for the fabrication of advanced micro- and nano-
patterned interfaces, however neithermaterial facilitates modulation
of substrate mechanical properties in a biologically relevant
range. The next section discusses biomechanical aspects of
T cell biomaterial interface design, including the mechanical
properties of biomaterial substrates.
Biomechanics of T cell interface design. Several cell types
have been shown to respond to alterations in the mechanical
properties of their environments30,98–102 however it is only recently
that these investigations have been extended to immune cells.
A number of immune receptors have been identified as mechano-
sensitive, where engagement of receptors with their cognate
ligands is sensitive to the force applied through each bond, with
the leukocyte catch bond in LFA-1–integrin binding being a well-
established example.37,103–106 Intriguingly, TCR–ligand affinity
has been shown to play a major role in determining cellular
activation levels. During thymic development, T cells with high
affinity interactions between their TCR and self-antigen bearing
pMHC are deleted to generate a T cell repertoire with low affinity
for self-antigens (4500 mM) and higher affinities for pMHC
clusters with foreign peptides (1–10 mM), helping to prevent
autoimmunity.22 During an immune response, high and low
affinity interactions between the TCR and pMHC lead to different
functional phenotypes,107,108 highlighting the ability of the TCR
to respond to affinity, and perhaps force, through the TCR.
To explore the role of rigidity on cellular activation, biomaterial
surfaces with varied mechanical properties have been fabricated.
Using planar poly(dimethyl siloxane) (PDMS) substrates func-
tionalised with stimulatory anti-CD3 antibodies, maximal
proliferation in CD4+ and CD8+ T cells has been observed in
cells cultured on surfaces with a rigidity ofo100 kPa compared
to 2 MPa.30 However, other studies on poly(acrylamide) (PA)
Integrative Biology Review Article
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surfaces describe maximal T cell responses on substrates with
rigidity of 200 kPa31 compared to softer substrates at 10 kPa.
Separately, B cells showed preferential activation on PA gels at
around 20 kPa (compared to softer 2 kPa substrates)98 and
hematopoietic stem cells demonstrated increased cell spreading
on much stiﬀer PA substrates100 of around 200 kPa compared to
less rigid matrices. The diﬀerences in these results pose inter-
esting questions on how cells sense rigidity, and whether various
material chemistries may play a role. It has been suggested that
cells may ‘‘feel’’ the rigidity of the chemical bond connecting the
ligand of interest to the substrate109,110 rather than the rigidity of
the substrate itself.
Force transduction by the TCR/CD3 complex has been
investigated using flexible micropillars coated with anti-CD3
to measure forces applied by the cell to the substrate.111,112
These experiments showed that T cells apply forces via the TCR/
CD3 complex to such bio-functionalized substrates, and implicitly
therefore to APC. In contrast, CD28 was shown to aﬀect force
transduction only indirectly by influencing intracellular signalling,
with no evidence of significant traction forces being applied
through the CD28 receptor itself. TCR-mediated traction forces
were of the order of 100 pN per 1 mm-diameter pillar, much
smaller than the forces observed in integrin-mediated cell
adhesion on similar substrates.
A plausible hypothesis to explain the mechanosensitivity of
the T cell is that mechanically-induced conformational changes
in TCR/CD3 are needed for activation. Such changes could be
induced by cytoskeletal pulling forces.84 It is well known that
cytoskeletal function is important to T cell function; surface
bound triggering requires an intact cytoskeleton,28 and changes
in the actin cytoskeleton compromise signalling in T cells as
discussed earlier, supporting this hypothesis.37,59,62–64,113,114
In several receptor types, such as selectins, there is a transition
between catch and slip bond systems at specific force values,
implying that the cell can sense force over a dynamic range
and that force can regulate conformational changes in these
systems.105,106 In vivo, these mechanisms are crucial for immune
cell extravasation from blood vessels to allow migration into
inflamed tissues. Immune cell extravasation is largely dependent
on L- and E/P-selectin adhesion receptors, which allow leukocytes
to first tether and roll along the activated endothelium and then
firmly adhere before squeezing into the tissue through gaps
between endothelial cells. Stabilisation of leukocyte adhesion to
the blood vessel wall requires a minimum level of fluid shear
stress in order to avoid inappropriate aggregation or adhesion
outside the vasculature. This has been called catch–slip transition
and explains how increasing levels of shear stress and thus force
applied to a specific receptor–ligand pair, can stabilize leukocyte
adhesion under flow.115–117
A similar mechanism could occur within the TCR, for example
exposing cryptic binding sites downstream of the TCR/CD3
machinery that are force sensitive, using a similar mechanism to
cellular force-sensing in the formation of focal adhesions.118,119
Additionally, the mechanical force applied through the TCR could
correlate with viral or infectious load, so that the number of
anchoring points and/or force loading provides the T cell with
additional information about the status of an APC. Intriguingly,
studies have demonstrated a link between the spatial distribution
of proteins on T cell surfaces, the intrinsic mechanical properties
of T cell, and the activation level of the cells.120
Importantly, a ‘receptor deformation model’ has been proposed,
which provides an explanation for TCR triggering under
physiological conditions, where the amount of one specific peptide
available is likely too small to allow activation based on TCR
crosslinking.94,95 The model suggests that the pulling force
associated with T cell motility induces a TCR conformation that
favours induction of downstream signalling. To fully explore
these mechanisms, advanced materials that vary rigidity simulta-
neously with other variables (such as ligand chemical linkage and
spatial nanopatterning) are required.
3-Dimensional interfaces
The natural T cell–APC interaction occurs in three dimensions
(3D) between two cells which are themselves 3D objects. In
addition to their overall shape, natural APCs and immune cell
surface membranes exhibit a range of micro topographical
features including invaginations, protrusions, and extending
nanotubes.121,122 Given the inherently 3D nature of immune
cells, and the wealth of 3D features present on their surfaces,
more complex biomaterial interfaces are starting to be developed to
explore the cellular response to altering these features. Here, we
describe interfaces that replicate the 3D aspects of cell surface
features, and move towards more complex systems.
Topography. Dendritic cells, the prototype APC, are known
to possess distinct lamellipodea, and are often characterized in
cartoons as ‘‘spiky cells’’. Despite this, there has been limited
study into the influence of these micro- and nano-scale features
on T cell activation. The dendritic cell protrusions may be a
strategy for increased cell membrane surface area to cell volume
ratio, allowing for an increase in pMHC available on the APC
surface, or alternatively, could provide a varied topography
required for activation.
Using advanced microfabrication techniques, micro-topo-
graphical features have been patterned on planar substrates
to explore their eﬀects on T cell stimulation. Large micro-pits
have been used to trap individual T cells122 and investigate
the morphology of the APC interface, however studies into the
eﬀect of topography itself are extremely limited. Although the
eﬀect of surface topography on T cell behaviour has not been
well studied, evidence from other immune cells suggests this
may be an important parameter to consider in stimulatory
biomaterial interface design. Neutrophil activation is enhanced
on budding, as opposed to smooth, microparticles.123 Similarly,
surface topography has been shown to induce phenotypic shifts
towards distinct subtypes in macrophages; titanium surfaces with
smooth or micro pitted features were able to induce macrophage
diﬀerentiation towards an ‘‘inflammatory’’ or ‘‘regenerative’’ pheno-
type, respectively.124
3D architecture. To more accurately replicate the 3D inter-
action between T cells and APCs, a range of spherical micro-
and nano-particle materials have been designed to boost T cell
activation. Many of these materials are primarily designed as
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vaccine therapies, which aim to induce enhanced immune
responses through the delivery of antigen to dendritic cells or
lymphoid organs. This antigen is then processed and presented
to T cells as part of the natural pMHC complex. Separately, the
closest mimic of the pMHC complex on the dendritic cell is
another cell engineered to express selected agonist ligands.
These biologically engineered materials possess natural fluid
lipid bilayers over the surface of the cell, intact actin cytoskeletons
that may be used to aid traction of force and so activation, and a
range of natural adhesive ligands such as integrins. The rational
design and targeted delivery of 3D spherical micro-, nano- and
cellular engineering material vaccine therapies has been reviewed
extensively elsewhere.7,8,13,20,66,125,126 In this section, we instead
focus on the key principles governing the 3D design of artificial
biomaterials that directly stimulate the T cell itself.
A range of materials have been used to fabricate fully synthetic
spherical constructs including polystyrene,127 PLGA,43 polymer
emulsions,128 and synthetic liposomes.48,49 These materials are
usually functionalized with proteins, either chemically linked or
adsorbed onto the material surface. Importantly, both the size
and shape of the material play an important role in cellular
activation.13,126,129 Non-spherical, micro-scale ellipsoid shapes
have been shown to enhance T cell activation when compared
to their spherical129 counterparts, possibly due to changes in
presented surface area or T cell membrane disruption. A range of
studies have explored the role of particle size in both vaccine
delivery strategies and, independently, phagocytosis of nano-
particles in several immune cell types.13,130 For T cells, it has
previously been shown that nanoscale particles are less eﬀective
than their microscale counterparts in stimulating T cells towards
activation.131,132 Particles of at least 4–5 mm diameter are thought
to be required to provide the minimum contact area133 needed
for full activation. The reasons for this are unclear, but are likely
to include the need for microscale contact areas to enable
receptor segregation (SMAC formation), or the inability of smaller
interfaces to establish long-range mechanical coupling across
distinct parts of the T cell as discussed in other sections of this
review.
Spherical interfaces with diameters above this 4–5 mm
threshold are therefore strong potential candidates for in vivo
therapeutic applications, and indeed polystyrene beads bio-
functionalized with anti-CD3 and anti-CD28 have been used to
stimulate T cells in clinical trials.12,134 Moving to more flexible
self-assembled materials, PEGylated liposomes have recently
proven successful in targeting up to 95% of circulating adoptively
transferred T cells48,49 offering great promise for future in vivo
therapies using multicomponent systems that are able to engage
selectively with target T cell sub-populations.
Fig. 3 Dynamic T cell interfaces with APC-mimicking biomaterials. (A) Biodegradable PLGA particles have been used to deliver surface bound and
soluble T cell signals, paracrine IL2 delivery seems to result in increased activation.50 (B) A schematic of paramagnetic nanoparticles functionalized with
anti-CD3 and anti-CD28, which represent the move towards dynamic biomaterials that are able to induce T cell activation in response to specific stimuli.
Copyright: (B) adapted with permission from ref. 51 Perica et al. ACS Nano, 2014, 8(3), 2252–2260, Copyright 2014 American Chemical Society.
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Interestingly, recent work in this area has outlined more
advanced materials for stimulation in 3D; Janus particles135
presenting focular CD3 protein micropatterns have been used
to stimulate T cells representing a move towards 3D materials
with controlled surface patterning. The design of 3D interfaces
that move from simple, single parameter interfaces towards
more complex architectures that consider several parameters at
a time will be the next step in T cell biomaterial design.
Dynamic interfaces
Natural T cell–APC interactions are dynamic in nature, with
distinct events occurring over a timescale that starts with cellular
stimulation in the first few seconds, followed by a complex
cascade of activation events occurring over several hours.136–138
Fully interactive innate and adaptive immune responses often
occur over several months, and in some cases, protective immune
response can last a lifetime. The sequence, duration and nature
of each step in the stimulation pathway can drastically affect
cellular outcome. In moving to more advanced biomaterial inter-
faces, it will be important to develop materials that can dynamically
control cellular behaviour. These materials should controllably alter
their properties in response to externally applied stimuli, and
therefore provide a range of cues to the cell that are conditioned
to specific environments, effectively modulating T cell behaviour.
An example includes the temporal delivery of stimulatory
signals to T cells, explored using biodegradable polymers. Fig. 3A
shows a schematic where polymer particles have been functionalized
with anti-CD3 and anti-CD28, and modified to contain the cytokine
IL2 that is either chemically linked to the particle surface or
encapsulated within the polymer matrix and released as the
polymer degrades.50
These materials have shown that paracrine release of IL2 results
in enhanced T cell activation compared tomaterials that present IL2
directly on the surface. In silico experiments whichmodel the release
of protein and cytokines from biodegradable materials50,132 suggest
that the kinetics of release may drastically aﬀect cellular behaviour.
In other fields, themanipulation ofmaterial physical properties
using external stimuli, such as temperature, pH, or UV light, has
been widely explored as a tool to regulate kinetic drug dosing,
ligand presentation and subsequent cell behaviour139–141 however
these studies are limited in respect to T cell stimulatory biomaterial
design. One notable example involves the manipulation of TCR
nanoclusters using functionalized para-magnetic particles.51 These
particles bind to TCR receptors on the cell surface, and naturally
aggregate in an applied magnetic field. The aggregation of these
particles induces TCR clustering, which leads to magnetically-
induced cell activation, shown schematically in Fig. 3B. We anti-
cipate that using a similar principle, TCR aggregation (and so
activation) could be induced using a range of stimuli response
biomaterials in future dynamic artificial immune synapse design.
Conclusions
The biomaterials described here exemplify a paradigm shift
in biomaterial design away from traditional ‘‘immune inert’’
materials towards materials that are specifically designed to
control, and perhaps elicit, specific immune cell behaviour. A
range of factors controlling T cell behaviour, such as spatial
patterning, substrate geometry and substrate mechanical properties
have been identified and individually explored using increasingly
complex static, responsive and dynamic biomaterial substrates.
Table 1 highlights the breadth of materials that have already been
fabricated to explore these parameters, but also indicates that there
is huge scope for development of more complex materials capable
of supporting artificial immune synapses, with many possible
parameter combinations as yet unaddressed.
The high level of interest in T cell biomaterial design arises
not only from the fundamental importance of modulating T cell
activation in human biology but also from the potential of these
materials to contribute to current therapeutic aims. Determining the
mechanisms that underpin phenotype specific induced activation
pathways will have important implications in future immuno-
therapeutic design. The long-term aim is for advanced biomaterial
interfaces to facilitate the generation or delivery of precisely-
controlled T cell populations of desired phenotypes for each
specific therapeutic application.
Static biomaterial interfaces, including nanopatterned and
rigidity-controlled substrates, present precisely-controllable stimuli
designed to induce a specific response in T cells, and have
delivered fundamental insights into the thresholds for diﬀerent
parameters to stimulate T cells. Observations from these works
highlight that the nano- and micro-patterned distribution of
TCR/CD3 ligands on stimulatory surfaces play a key role in T cell
activation, with signalling thresholds directly related to the
precise positioning of TCR/CD3 complexes and co-stimulatory
receptors.
Other studies have focused on the role of substrate mechanical
properties in controlling T cell activation. These studies are limited
in number, but indicate that force appears to aﬀect activation
through the TCR/CD3 complex. It is important to note that many
of the variables investigated, including ligand–receptor spacing
and protein patterning, may be intrinsically linked to adhesion
force. To fully understand the importance of these parameters,
more complex biomaterials will be needed to isolate and re-combine
them, allowing an exploration of the relative contributions of each of
these factors.
Responsive materials present stimuli to cells, but can be
remodelled by the responding cells to allow modulation of
behaviour driven by the cell. An important example is the fluid
lipid bilayer system, which has provided a wealth of information
about the rearrangement of ligands following activation. A
variety of ligand protein distribution sizes and patterns have
been observed on the cell both before and during activation.
Moving forward in the design of immune cell–biomaterial interfaces,
it will be important to understand the nature of these differences,
and whether they may be due to the behaviour of distinct T cell
phenotypes.
Finally, dynamic materials are those that respond to external
stimuli to induce a specific state in the cell only under certain
conditions. Research on dynamic biomaterials for themanipulation
of immune cell behaviour is still in its infancy, but oﬀers
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great promise, using varying kinetic and stimuli responsive
biomaterials to fine tune immune responses and potentially
enable localized, rather than systemic, control of immune
behaviour. Coupled with cell engineering strategies, these
materials could enable a more complex temporal and spatial
regulation of immune cell behaviour to deliver individually
engineered immune therapies.
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